Greg Yothers Selected Research

Greg Yothers Research Topics

Disease

46	Colonic Neoplasms (Colon Cancer) 11/2022 - 11/2006
29	Neoplasms (Cancer) 01/2022 - 06/2002
10	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2002
9	Rectal Neoplasms (Rectal Cancer) 01/2022 - 11/2009
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2008
8	Carcinoma (Carcinomatosis) 04/2017 - 05/2006
4	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2021 - 09/2009
4	Diarrhea 01/2021 - 11/2007
3	Pain (Aches) 12/2021 - 08/2012
3	Microsatellite Instability 01/2021 - 06/2011
2	Vomiting 01/2021 - 08/2012
2	Obesity 04/2013 - 02/2012
2	Hemorrhage 09/2012 - 07/2009
1	Hot Flashes 12/2021
1	Thrombosis (Thrombus) 12/2021
1	Arthralgia (Joint Pain) 12/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Anemia 01/2021
1	Leukopenia 01/2021
1	Nausea 01/2021
1	Neutropenia 01/2021
1	Stomatitis 01/2021
1	Residual Neoplasm 12/2020
1	Fatigue 01/2017
1	Hypesthesia (Numbness) 11/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2012
1	Migraine Disorders (Migraine) 08/2012
1	Endometrial Neoplasms (Endometrial Cancer) 08/2012
1	Death (Near-Death Experience) 11/2005
1	Cardiotoxicity 11/2005
1	Heart Failure 10/2005

Drug/Important Bio-Agent (IBA)

29	Fluorouracil (Carac)FDA LinkGeneric 02/2022 - 07/2004
26	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2022 - 06/2007
17	Leucovorin (Folinic Acid)FDA Link 01/2021 - 05/2006
15	Sodium Glutamate (Accent)IBA 11/2021 - 10/2007
7	Capecitabine (Xeloda)FDA Link 11/2021 - 07/2013
7	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 06/2002
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017 - 06/2002
7	Bevacizumab (Avastin)FDA Link 04/2017 - 07/2009
5	Biomarkers (Surrogate Marker)IBA 04/2017 - 08/2007
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2012 - 06/2002
4	Trastuzumab (Herceptin)FDA Link 11/2012 - 06/2002
4	B 31IBA 11/2012 - 06/2002
3	Estrogen ReceptorsIBA 01/2022 - 07/2004
3	Tamoxifen FDA LinkGeneric 12/2021 - 06/2005
3	Pharmaceutical PreparationsIBA 12/2021 - 08/2012
3	ErbB Receptors (EGF Receptor)IBA 08/2017 - 11/2005
3	AnthracyclinesIBA 08/2017 - 11/2005
3	ParaffinIBA 12/2013 - 08/2007
3	TegafurIBA 07/2013 - 05/2006
3	UracilIBA 07/2013 - 05/2006
2	Anastrozole (Arimidex)FDA LinkGeneric 12/2021 - 11/2021
2	human ERBB2 proteinIBA 01/2021 - 11/2005
2	Cetuximab (Erbitux)FDA Link 01/2021 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 06/2011 - 06/2002
2	RNA (Ribonucleic Acid)IBA 09/2010 - 08/2007
2	Biological FactorsIBA 02/2010 - 09/2009
1	taxaneIBA 01/2022
1	Hormones (Hormone)IBA 11/2021
1	pembrolizumabIBA 08/2021
1	Trinitrotoluene (TNT)IBA 08/2021
1	olaparibIBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 08/2017
1	Codon (Codons)IBA 04/2017
1	XELOXIBA 03/2016
1	CDX2 Transcription FactorIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2013
1	OF 743IBA 11/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2010
1	Formaldehyde (Formol)FDA Link 08/2007
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2005
1	Methotrexate (Mexate)FDA LinkGeneric 07/2004

Therapy/Procedure

27	Therapeutics 01/2022 - 07/2004
23	Adjuvant Chemotherapy 11/2022 - 06/2005
12	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
7	Neoadjuvant Therapy 01/2022 - 01/2015
3	Radiotherapy 11/2021 - 06/2014
1	Treatment Delay 01/2021
1	Combined Modality Therapy 01/2018
1	Activities of Daily Living (ADL) 01/2017
1	Investigational Therapies (Experimental Therapy) 09/2016
1	Precision Medicine 01/2016
1	Proctectomy 01/2015
1	Chemoradiotherapy 11/2009
1	Adjuvant Chemoradiotherapy 11/2009